Xiangyang Zhu

Title: Innovations of Xiangyang Zhu

Introduction

Xiangyang Zhu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents, his work focuses on innovative solutions for treating diseases related to programmed death-ligand 1 (PD-L1).

Latest Patents

Xiangyang Zhu's latest patents include groundbreaking inventions. One of his notable patents is a binder against programmed death-ligand and its application. This invention provides an anti-PD-L1 monoclonal antibody that can be utilized to prepare a drug aimed at preventing or treating diseases associated with PD-L1. Another significant patent is the anti-PD-L1/VEGF bifunctional antibody and its use. This invention offers a bispecific antibody that can simultaneously bind to both VEGF and PD-L1, thereby exerting a therapeutic effect on tumor cells that are positive for these markers, particularly malignant tumor cells.

Career Highlights

Throughout his career, Xiangyang Zhu has worked with notable companies in the biotechnology sector. He has been associated with Huabo Biopharm (Shanghai) Co., Ltd. and Jaka Robotics Co., Ltd. His work in these organizations has contributed to advancements in medical treatments and technologies.

Collaborations

Xiangyang Zhu has collaborated with several professionals in his field, including Mingqing Cai and Ling Yu. These collaborations have fostered innovation and development in his research endeavors.

Conclusion

Xiangyang Zhu's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly in the fight against cancer.